Clinical Trial Update: Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing clinico-biological monitoring to pre-emptive rituximab for ANCA reappearance in granulomatosis with polyangiitis and microsco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: ANCA Associated Vasculitis (AAV), Polyangiitis (GPA) | Phase 4 | Status: NOT_YET_RECRUITING